Cytidine-5′-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma11The authors have no proprietary interest in the development or marketing of this or a competing drug.-Reference-Cited by-同舟云学术

Cytidine-5′-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma11The authors have no proprietary interest in the development or marketing of this or a competing drug.

Published:1999-06 Issue:6 Volume:106 Page:1126-1134
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Parisi Vincenzo,Manni Gianluca,Colacino Gaspare,Bucci Massimo G

Publisher

Elsevier BV

Subject

Ophthalmology

Reference69 articles.

1. Detectability of early glaucomatous field defects. A controlled comparison of Goldmann versus Octopus perimetry;Krieglstein,1981

2. What constitutes a glaucomatous visual field defect;Werner;Seminars in Ophthalmology,1992

3. Color vision defects in ocular hypertension and glaucoma. Quantification with a computer-driven color television system;Gunduz;Arch Ophthalmol,1988

4. A simple grating test of contrast sensitivity;Arden;Invest Ophthalmol Vis Sci,1978

5. Contrast sensitivity gratings in glaucoma family screening;Hitchings;Br J Ophthalmol,1981

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects;Molecular Aspects of Medicine;2023-12

2. Efficacy of citicoline as a supplement in glaucoma patients: A systematic review;PLOS ONE;2023-09-28

3. Cholinergic modulation of sensory perception and plasticity;Neuroscience & Biobehavioral Reviews;2023-09

4. The effect of citicoline oral solution on quality of life in patients with glaucoma: the results of an international, multicenter, randomized, placebo-controlled cross-over trial;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-01-14

5. Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance;Journal of Personalized Medicine;2022-11-10